| Mrs Jennifer Bonaro Vanderwerff, SLP | |
|
222 Nw 200th St, Shoreline, WA 98177-2517 | |
| (206) 228-2729 | |
| (206) 691-8698 |
| Full Name | Mrs Jennifer Bonaro Vanderwerff |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 222 Nw 200th St, Shoreline, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336283282 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL00004122 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jennifer Bonaro Vanderwerff, SLP 222 Nw 200th St, Shoreline, WA 98177-2517 Ph: (206) 228-2729 | Mrs Jennifer Bonaro Vanderwerff, SLP 222 Nw 200th St, Shoreline, WA 98177-2517 Ph: (206) 228-2729 |
News Archive
The first human study using gene transfer to treat erectile dysfunction (ED) shows promising results and suggests the potential for using the technology to treat overactive bladder, irritable bowel syndrome and asthma, according to the researchers.
New mums are being urged to be cautious about returning to work too quickly, after a QUT study found one in two were still excessively sleepy four months after giving birth.
New research has identified a growing trend for trials of new cancer treatments to be stopped prematurely before the therapies' risks and benefits have been properly evaluated.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE(bortezomib), which updates the label to include the subcutaneous method of administration in all approved indications: multiple myeloma and mantle cell lymphoma after at least one prior therapy.
DaVita Kidney Care, a division of DaVita Inc., a leading provider of kidney care services in the United States, today announced results of the first performance year in the Centers for Medicare and Medicaid Services Comprehensive ESRD Care Model as an ESRD Seamless Care Organization.
› Verified 2 days ago
Kristi Jill Marion, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2402 Nw 195th Pl, Shoreline, WA 98177 Phone: 206-364-3777 Fax: 206-364-3999 | |
Mrs. Jisun Park, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 816 Ne 190th St, Shoreline, WA 98155 Phone: 206-364-3777 | |
April Grace Lagutang Lloyd, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2818 Ne 145th St, Shoreline, WA 98155 Phone: 206-418-2900 | |
Lisa J Vanhorne, MSCCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 340 Nw 177th St, Shoreline, WA 98177 Phone: 206-546-5012 | |
Sarah Burt, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2402 Nw 195th Pl, Shoreline, WA 98177 Phone: 206-364-3777 Fax: 206-364-3999 | |
Francesca Blasen, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2402 Nw 195th Pl, Shoreline, WA 98177 Phone: 206-364-3777 Fax: 206-364-3999 | |
Andrea Ryan, MACCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16357 Aurora Ave N, Shoreline, WA 98133 Phone: 206-542-3103 Fax: 206-542-4813 |